Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Adaptol

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
AIM: To assess the efficacy and safety of adaptol in anxiety-asthenic disorders in patients with chronic cerebral ischemia (CCI… Expand
Is this relevant?
2016
2016
AIM To compare the effects of the daytime anxiolytic adaptol and the tranquilizer/nootropic drug noophen on target symptoms… Expand
Is this relevant?
2013
2013
AIM To evaluate the efficacy and safety of adaptol in a dose of 1500-2000 mg/day in combination therapy for anxiety disorders (AD… Expand
Is this relevant?
2013
2013
AIM: To evaluate the effect of the anxiolytic adaptol on blood pressure (BP) level in its concurrent use with a fixed dose… Expand
Is this relevant?
2012
2012
We have studied the efficacy of adaptol in the treatment of 45 patients with somatoform dysfunction of the autonomic nervous… Expand
Is this relevant?
Review
2012
Review
2012
The analysis of the available in the modern literature researches allows us to consider Adaptol (active substance mebicarum) as… Expand
Is this relevant?
2011
2011
A total of 336 children aged 7–14 years with signs of school maladaptation (SMA) were studied. Anxiety disorders were detected in… Expand
  • table 1
  • table 2
Is this relevant?
2010
2010
The efficacy of Adaptol (a non-benzodiazepine tranquilizer) in the treatment of children with attention deficit hyperactivity… Expand
  • table 1
Is this relevant?